Pharmaceuticals - a healthy course

• Published 20 Aug 2009

China's pharmaceutical industry is set to benefit from recent healthcare reform spending, as well as government support for the development of the traditional Chinese medicine sector.

China's rapidly aging population, urbanisation and increasingly fast lifestyles are fostering a healthy business for the pharmaceutical industry.

China Confidential Funds

China Confidential Funds, a new research service launched by FT China Confidential, is dedicated to illuminating the mainland fund industry. Our team of fund industry experts in Shanghai search out the interesting trends in fund performance, strategy, interactions with overseas funds, regulatory changes, distribution and management. We also use a proprietary system to track the emerging flows of Chinese money. Click here to find out more.

Other Articles on this Issue

• Macro View

  A moment of truth

• Funds Data

  China zeal wavers

• Forbidden City

  Iron and awe

• The Big Call

  A local financial time bomb

• Postcard From No 528

  Wobbling on the liquidity high wire

• Financial China

  Insurance - a structural play

  Ping An - not so tranquil

  China Life - in the balance

• Capital Intensive China

  Developers defy doomsayers

• The Best of Chinese Commentators

  Inflation, inflation, inflation

  Sovereign wealth

• Consumer China

  Sinovac and swine flu

  Sinopharm - a new contender

  Simcere – not immune

  Tongrentang – TCM bellwether

• Guest Column

  Bright prospects

• View issue